Computer simulations to investigate the causes of T-wave notching

Journal of Electrocardiology
Loriano GaleottiDavid G Strauss

Abstract

Drugs that cause strong hERG potassium channel block (e.g., dofetilide, quinidine) cause T-wave notching. It has been suggested that this is due to prolongation of mid-myocardial (M) cells' action potential duration relative to endocardial and epicardial cells. However, the role of M cells in intact human hearts is debated. We simulated 2025 electrocardiograms representing changes in ventricular action potentials using the equivalent double layer mode that does not include M-cells. Action potential changes included prolongation, triangularization, squaring, and bumps in late repolarization, which have been observed experimentally and in single cell models with block of the hERG potassium channel. Changes were applied globally and spatially dispersed. Action potential bumps (slowing in late repolarization) produced T-wave notching similar to that observed clinically in healthy subjects receiving dofetilide or quinidine. Conversely, all other action potential changes (i.e., prolongation, triangularization, squaring), either global or spatially dispersed, resulted in T-wave changes, but did not cause T-wave notching. This study demonstrates that M-cells are not required to simulate T-wave notching.

References

May 30, 2001·Cardiovascular Research·C Antzelevitch
Jan 20, 2004·Heart·A van Oosterom, T F Oostendorp
Jul 5, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Rashmi R Shah, Luc M Hondeghem
Sep 23, 2008·Journal of Electrocardiology·Mads P AndersenJohannes J Struijk
Jan 23, 2009·Journal of Electrocardiology·Loriano GaleottiEinar Heiberg
Jun 30, 2009·Annals of Biomedical Engineering·Peter M van DamAdriaan van Oosterom
Oct 8, 2009·Circulation. Arrhythmia and Electrophysiology·Tobias OpthofMichiel J Janse
May 25, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Loriano GaleottiDavid G Strauss
Dec 18, 2013·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Apr 15, 2015·Journal of the American Heart Association·Jose VicenteDavid G Strauss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.